Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2077-0383
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: https://doi.org/10.3390/jcm8060792
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Medizinische Fakultät Charité - Universitätsmedizin Berlin
- (wann)
-
2019
- Urheber
-
Tadic, Marijana
Cuspidi, Cesare
Plein, Sven
Belyavskiy, Evgeny
Heinzel, Frank
Galderisi, Maurizio
- DOI
-
10.17169/refubium-26670
- URN
-
urn:nbn:de:kobv:188-refubium-26909-0
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tadic, Marijana
- Cuspidi, Cesare
- Plein, Sven
- Belyavskiy, Evgeny
- Heinzel, Frank
- Galderisi, Maurizio
- Medizinische Fakultät Charité - Universitätsmedizin Berlin
Entstanden
- 2019
Ähnliche Objekte (12)
Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Coagulation disorders and thrombotic complications in heart failure with preserved ejection fraction
Mechanistic differences in mouse models of heart failure with preserved ejection fraction
Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Histone deacetylase 4 regulates heart failure with preserved ejection fraction through its enzymatic domain
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Coagulation disorders and thrombotic complications in heart failure with preserved ejection fraction
Mechanistic differences in mouse models of heart failure with preserved ejection fraction
Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Histone deacetylase 4 regulates heart failure with preserved ejection fraction through its enzymatic domain
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Coagulation disorders and thrombotic complications in heart failure with preserved ejection fraction
Mechanistic differences in mouse models of heart failure with preserved ejection fraction
Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Histone deacetylase 4 regulates heart failure with preserved ejection fraction through its enzymatic domain
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population